GLP-1s hit 7% of U.S. prescriptions—plus the FDA pulls a major warning
“GLP-1 Friendly” foods are everywhere, oral Wegovy’s rollout is accelerating, and a new prescribing snapshot shows just how mainstream these meds have become.
1) Today’s News Headlines
GLP-1 medications just crossed a new “mainstream” threshold: more than 7% of all U.S. prescriptions as of December 2025, per new Truveta Research data. (truveta.com)
At the same time, the FDA is telling manufacturers to remove suicide-related warnings from certain GLP-1 weight-loss drug labels after reviewing the evidence. (apnews.com)
2) Today’s Top Stories
GLP-1s now make up 1 in 14 prescriptions in the U.S. (Truveta)
A new Truveta Research analysis reports that GLP-1 RA prescriptions accounted for >7% of all prescriptions in December 2025. The dataset also notes that tirzepatide (Mounjaro/Zepbound) remains the most prescribed in both anti-diabetic and anti-obesity categories, with prescribing rising from September to December 2025 even as first-time prescribing dipped over the same period (a pattern they say aligns with holiday seasons). (truveta.com)
Why it matters: This isn’t a niche trend anymore—GLP-1s are now a major pillar of metabolic care, which will shape insurance, supply chains, and clinical standards.
Source: Truveta Research (truveta.com)
FDA asks companies to remove suicide warnings from GLP-1 weight-loss labels
The FDA has advised Novo Nordisk and Eli Lilly to remove suicide-related warnings on certain GLP-1 weight-loss drugs (including Wegovy, Saxenda, and Zepbound), citing a review that found no increased risk of suicidal thoughts or behaviors tied to GLP-1 receptor agonists for obesity. (apnews.com)
Why it matters: Label language affects patient anxiety, prescribing decisions, and stigma—especially for people already navigating mental health while changing weight and eating patterns.
Source: Associated Press (apnews.com)
“GLP-1 Friendly” food labels are spreading—dietitians say: proceed carefully
Food brands are increasingly marketing products as “GLP-1 Friendly,” but the term isn’t FDA-regulated, and experts urge people to focus on the basics (protein, fiber, hydration, tolerability) rather than label hype. (apnews.com)
Why it matters: These labels can help people shop—but they can also distract from what actually reduces side effects and supports muscle retention during weight loss.
Source: Associated Press (apnews.com)
Oral Wegovy is ramping up—and the pill era is here
Novo Nordisk’s new oral Wegovy launch is drawing attention as an option for people who are injection-averse, with early prescription data suggesting a strong start. (barrons.com)
Why it matters: Oral options could expand access and adherence—but may also come with different dosing routines, coverage rules, and expectations vs. injectables.
Source: The Washington Post (washingtonpost.com)
3) Deep Dive (Wednesday: Community Voices)
What “GLP-1 Friendly” really looks like in real life (and why it’s not a product)
If you’ve spent any time in weight-loss communities lately, you’ve probably noticed a consistent theme: the people doing best long-term (with or without meds) aren’t chasing “perfect” foods—they’re building repeatable defaults.
Here’s a practical, community-inspired framework you can use today—especially if appetite is lower (GLP-1 or no GLP-1):
- Build meals around a “protein anchor.”
When portions shrink, protein tends to shrink first—yet it’s one of the biggest protectors of satiety and lean mass. “GLP-1 Friendly” should usually mean protein-forward, not just “low-cal” or “keto-ish.” (Think: Greek yogurt, beans/lentils, fish, chicken, tofu.) - Fiber is a side-effect strategy, not just a weight-loss strategy.
Constipation is common with GLP-1s, and fiber + fluids + routine movement often beat random “cleanses.” If you’re sensitive, increase fiber slowly and pair it with water. - “Tolerable foods” count—especially during dose changes.
On higher-nausea days, perfectionism backfires. It’s okay to lean on bland, simple options—then rebuild variety when symptoms calm down. - The label isn’t the plan—your pattern is the plan.
A “GLP-1 Friendly” badge doesn’t guarantee you’ll feel good after eating it. Many people do better using a quick check:- Protein: did I get a real dose?
- Fiber/produce: did something plant-based show up?
- Hydration: am I behind?
- Trigger load: is this super fatty/spicy/sugary in a way that usually backfires?
Myth-bust (kindly): “GLP-1 Friendly” doesn’t mean “weight-loss guaranteed.”
It’s marketing, and it’s not FDA-defined—so let your symptoms, labs, and sustainable habits lead. (apnews.com)
4) Quick Hits
- A new Truveta snapshot suggests first-time GLP-1 prescribing dipped from Sept→Dec 2025, even while overall prescribing rose—likely reflecting holiday-season patterns. (truveta.com)
- The FDA’s move to remove suicide warnings may help reduce fear, but mental health monitoring still matters—especially during rapid weight change and identity shifts around food. (apnews.com)
- “GLP-1 Friendly” products are popping up across major brands; experts emphasize reading nutrition panels and prioritizing protein/fiber basics. (apnews.com)
- Oral GLP-1s are accelerating competition and could widen the patient pool beyond injection users. (washingtonpost.com)
- If you’re on semaglutide and struggling with food choices, dietitians continue to emphasize nutrient density (protein, produce, fiber) over “tiny meals of whatever.” (eatingwell.com)
- Reminder: “more access” doesn’t automatically mean “more adherence”—side-effect management and routines still drive outcomes.
5) By The Numbers
>7% — GLP-1 receptor agonists accounted for more than 7% of all U.S. prescriptions as of December 2025, per Truveta Research. (truveta.com)
What it means: GLP-1s are now a major, system-level part of U.S. healthcare—not a niche obesity treatment.
Why you should care: As utilization grows, so will employer benefit decisions, prior authorization rules, and the availability of specialized support (dietitians, strength programs, medication counseling).
6) Ask The Community
What’s your most reliable “default meal” when motivation is low—but you still want to support fat loss and metabolic health?
7) Tomorrow’s Preview
Expert Insights (Q&A): “I’m losing weight but my energy is crashing—am I under-eating protein, missing carbs, or sleeping poorly?” We’ll break down the most common culprits and what to try first.